EP Patent

EP3838267A1 — Edoxaban tablets

Assigned to Biohorm SL · Expires 2021-06-23 · 5y expired

What this patent protects

The present invention relates to solid pharmaceutical formulations comprising edoxaban as an active ingredient, namely tablets comprising edoxaban, a first diluent and a second diluent in its composition having good dissolution properties, and to a process for producing the same.

USPTO Abstract

The present invention relates to solid pharmaceutical formulations comprising edoxaban as an active ingredient, namely tablets comprising edoxaban, a first diluent and a second diluent in its composition having good dissolution properties, and to a process for producing the same.

Drugs covered by this patent

Patent Metadata

Patent number
EP3838267A1
Jurisdiction
EP
Classification
—
Expires
2021-06-23
Drug substance claim
No
Drug product claim
No
Assignee
Biohorm SL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.